NIM
NXTM

Needham Investment Management’s NxStage Medical Inc. NXTM Stock Holding History

Needham Investment Management’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-10,000
Closed -$127K – 126
2014
Q1 		$127K Sell
10,000
-110,000
-92% -$1.43M 0.03% 116
2013
Q4 		$1.2M Buy
120,000
+50,000
+71% +$568K 0.25% 70
2013
Q3 		$921K Buy
70,000
+25,000
+56% +$328K 0.21% 73
2013
Q2 		$643K Buy
+45,000
New +$566K 0.15% 81

Other funds holding NXTM

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BA
Broadview Advisors Milwaukee, Wisconsin $324M AUM 0.76% 1-Year Est. Return

Needham Investment Management's NXTM Position: Q2 2014 in Review

Needham Investment Management sold out of NxStage Medical Inc. (NXTM) in Q2 2014, closing a stake of 10,000 shares — an estimated $127K sold.

Needham Investment Management first reported a position in NXTM in Q2 2013 and held it in 4 quarters. The position peaked at $1.2M in Q4 2013. 115 funds tracked by Wall St. Rank hold NXTM as of Q2 2014.

  • Needham Investment Management reported no remaining NxStage Medical Inc. position as of Q2 2014 after selling out during the quarter.
  • Needham Investment Management sold 10,000 NxStage Medical Inc. shares in Q2 2014, an estimated $127K.
  • Needham Investment Management first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 4 quarters.
  • Needham Investment Management's NxStage Medical Inc. position peaked at $1.2M in Q4 2013.
  • 115 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q2 2014.

Based on Needham Investment Management's 13F filing for Q2 2014, filed 14 Aug 2014.